Model of a Queuing Approach for Patient Accrual in Phase 1 Oncology Studies

Volume: 3, Issue: 5, Pages: e204787 - e204787
Published: May 13, 2020
Abstract
Phase 1 cancer studies, which guide dose selection for subsequent studies, are almost 3 times more prevalent than phase 3 studies and have a median study duration considerably longer than 2 years, which constitutes a major component of drug development time.To discern a method to reduce the duration of phase 1 studies in adult and pediatric cancer studies without violating risk limits by better accommodating the accrual and evaluation process...
Paper Details
Title
Model of a Queuing Approach for Patient Accrual in Phase 1 Oncology Studies
Published Date
May 13, 2020
Volume
3
Issue
5
Pages
e204787 - e204787
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.